Kidney transplantation is the treatment of choice for patients with end-stage kidney failure. However, the life of a kidney transplant is limited due to unrecognized immune injury. There is no sensitive, non-invasive method to detect this injury at an early-stage. We have developed a reliable, inexpensive, and noninvasive assay to monitor kidney injury.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 1900 Alameda De Las Pulgas,
- Phone
- +1 833 697 7268
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nephrosant.com
- HQ
- San Mateo, California
Nephrosant, Inc. Questions
Nephrosant, Inc.'s helpline number is +1 833 697 7268
Nephrosant, Inc.'s website is nephrosant.com
Nephrosant, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nephrosant
Nephrosant, Inc. has
5 employees.
View email and phone details for 5
employees at Nephrosant, Inc..
Nephrosant, Inc.'s industry is
Biotechnology Research
Nephrosant, Inc.'s top competitors are
Slingshot Biosciences,
Cpg Diagnostics, Inc.,
Caredx, Inc.,
Glyphic Biotechnologies,
Tenon Medical, Inc.,
Esperto Medical,
Verici Dx,
Renalytix,
Nephros,
Pier 70 Ventures.
Nephrosant, Inc.'s categories are Biotechnology Research
Nephrosant, Inc.'s founding year is 2017
